Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: An overview
Open Access
- 1 February 2006
- journal article
- review article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 29 (1) , 3-20
- https://doi.org/10.1007/s10545-006-0106-5
Abstract
Hyperhomocysteinaemia has been regarded as a new modifiable risk factor for atherosclerosis and vascular disease. Homocysteine is a branch-point intermediate of methionine metabolism, which can be further metabolised via two alternative pathways: degraded irreversibly through the transsulphuration pathway or remethylated to methionine by the remethylation pathway. Both pathways are B-vitamin-dependent. Plasma homocysteine concentrations are determined by nongenetic and genetic factors. The metabolism of homocysteine, the role of B vitamins and the contribution of nongenetic and genetic determinants of homocysteine concentrations are reviewed. The mechanisms whereby homocysteine causes endothelial damage and vascular disease are not fully understood. Recently, a link has been postulated between homocysteine, or its intermediates, and an alterated DNA methylation pattern. The involvement of epigenetic mechanisms in the context of homocysteine and atherosclerosis, due to inhibition of transmethylation reactions, is briefly overviewed.Keywords
This publication has 233 references indexed in Scilit:
- G80A reduced folate carrier SNP modulates cellular uptake of folate and affords protection against thrombosis via a non homocysteine related mechanismLife Sciences, 2005
- A common insertion/deletion polymorphism of the thymidylate synthase (TYMS) gene is a determinant of red blood cell folate and homocysteine concentrationsHuman Genetics, 2005
- The thymidylate synthase tandem repeat polymorphism is not associated with homocysteine concentrations in healthy young subjectsHuman Genetics, 2004
- Effects of the glutamate carboxypeptidase II (GCP2 1561C>T) and reduced folate carrier (RFC1 80G>A) allelic variants on folate and total homocysteine levels in kidney transplant patientsKidney International, 2003
- Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levelsHuman Genetics, 2002
- Dysfunction of Nitric Oxide Mediation in Isolated Rat Arterioles With Methionine Diet–Induced HyperhomocysteinemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitusKidney International, 1999
- Redox Status and Protein Binding of Plasma Homocysteine and Other Aminothiols in Patients With Early-Onset Peripheral Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial DiseaseNew England Journal of Medicine, 1985
- Moderate homocysteinemia--a possible risk factor for arteriosclerotic cerebrovascular disease.Stroke, 1984